[{"id":"59306281-9d17-43db-95fc-ecad547b1392","acronym":"","url":"https://clinicaltrials.gov/study/NCT05719558","created_at":"2023-02-09T16:00:40.694Z","updated_at":"2025-02-25T14:03:18.450Z","phase":"Phase 1","brief_title":"A Study of ASP1002 in Adults for Treatment of Solid Tumors","source_id_and_acronym":"NCT05719558","lead_sponsor":"Astellas Pharma Global Development, Inc.","biomarkers":" HER-2 • ER • PGR","pipe":" | ","alterations":" HER-2 negative","tags":["HER-2 • ER • PGR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ASP1002"],"overall_status":"Recruiting","enrollment":" Enrollment 210","initiation":"Initiation: 03/13/2023","start_date":" 03/13/2023","primary_txt":" Primary completion: 04/30/2028","primary_completion_date":" 04/30/2028","study_txt":" Completion: 05/31/2028","study_completion_date":" 05/31/2028","last_update_posted":"2025-02-19"}]